Is Jasper Therapeutics, Inc. (JSPR) a Buy, Sell, or Hold?
Jasper Therapeutics, Inc.
NASDAQ:JSPR
$0.692 USD
-$0.03 (-4.26%)
- Volume
- 619.64K
- Average Volume
- 501.05K
- Market Capitalization
- $11.25M
- P/E Ratio
- -0.20
- Dividend Yield
- 0.00%
- Price Target
- $3.00
- Year High
- $3.52
- Year Low
- $0.32
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.26
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
25
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
1
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 900
JSPR Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
JSPR Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Mahal Jeetinder Singh | director, officer: CEO and President | 2026-02-06 | A-Award | 1.35 | 2026-02-10 |
| MARTELL RON | director, officer: President, CEO and Director | 2026-01-02 | A-Award | 1.84 | 2026-01-05 |
| Mahal Jeetinder Singh | officer: Chief Operating Officer | 2026-01-02 | A-Award | 1.84 | 2026-01-05 |
| CROSS HERB | officer: Chief Financial Officer | 2026-01-02 | A-Award | 1.84 | 2026-01-05 |
| WIGGANS THOMAS G | director | 2025-09-22 | P-Purchase | 2.43 | 2025-09-24 |
| WIGGANS THOMAS G | director | 2025-09-22 | P-Purchase | 2.92 | 2025-09-24 |
| Lucas Svetlana | director | 2025-09-22 | P-Purchase | 2.43 | 2025-09-24 |
| Lucas Svetlana | director | 2025-09-22 | P-Purchase | 2.92 | 2025-09-24 |
| MARTELL RON | director, officer: President and CEO | 2025-09-22 | P-Purchase | 2.43 | 2025-09-24 |
| MARTELL RON | director, officer: President and CEO | 2025-09-22 | P-Purchase | 2.92 | 2025-09-24 |
| Shizuru Judith Anne | director | 2025-09-22 | P-Purchase | 2.43 | 2025-09-24 |
| Shizuru Judith Anne | director | 2025-09-22 | P-Purchase | 2.92 | 2025-09-24 |
| Brun Scott C. | director | 2025-07-03 | A-Award | 6.77 | 2025-07-03 |
| EMSTER KURT VON | director | 2025-07-03 | A-Award | 6.77 | 2025-07-03 |
| Shizuru Judith Anne | director | 2025-07-03 | A-Award | 6.77 | 2025-07-03 |
| Nolet Chris | director | 2025-07-03 | A-Award | 6.77 | 2025-07-03 |
| Kapoor Vishal | director | 2025-07-03 | A-Award | 6.77 | 2025-07-03 |
| WIGGANS THOMAS G | director | 2025-07-03 | A-Award | 6.77 | 2025-07-03 |
| Lucas Svetlana | director | 2025-07-03 | A-Award | 6.77 | 2025-07-03 |
| MARTELL RON | director, officer: President and CEO | 2025-06-04 | A-Award | 6 | 2025-06-06 |
| Mahal Jeetinder Singh | officer: Chief Operating Officer | 2025-06-04 | A-Award | 6 | 2025-06-06 |
| CROSS HERB | officer: Chief Financial Officer | 2025-06-04 | A-Award | 6 | 2025-06-06 |
| Tucker Edwin Jonathan | officer: Chief Medical Officer | 2025-06-04 | A-Award | 6 | 2025-06-06 |
| Mahal Jeetinder Singh | officer: Chief Operating Officer | 2025-02-13 | A-Award | 6.2 | 2025-02-18 |
| MARTELL RON | director, officer: President, CEO and Director | 2025-02-13 | A-Award | 6.2 | 2025-02-18 |
| CROSS HERB | officer: Chief Financial Officer | 2025-02-13 | A-Award | 6.2 | 2025-02-18 |
| Tucker Edwin Jonathan | officer: Chief Medical Officer | 2025-02-13 | A-Award | 6.2 | 2025-02-18 |
| Mahal Jeetinder Singh | officer: Chief Operating Officer | 2024-12-12 | M-Exempt | 7.1 | 2024-12-12 |
| Mahal Jeetinder Singh | officer: Chief Operating Officer | 2024-12-12 | S-Sale | 22.11 | 2024-12-12 |
| Mahal Jeetinder Singh | officer: Chief Operating Officer | 2024-12-12 | M-Exempt | 7.1 | 2024-12-12 |
| Mahal Jeetinder Singh | officer: Chief Operating Officer | 2024-09-12 | M-Exempt | 7.1 | 2024-09-12 |
| Mahal Jeetinder Singh | officer: Chief Operating Officer | 2024-09-12 | S-Sale | 21.2263 | 2024-09-12 |
| Mahal Jeetinder Singh | officer: Chief Operating Officer | 2024-09-12 | M-Exempt | 7.1 | 2024-09-12 |
| Lucas Svetlana | director | 2024-06-18 | A-Award | 23.19 | 2024-06-20 |
| Lucas Svetlana | director: | 2024-06-18 | 0 | 2024-06-20 | |
| Mahal Jeetinder Singh | officer: Chief Operating Officer | 2024-06-12 | M-Exempt | 7.1 | 2024-06-12 |
| Mahal Jeetinder Singh | officer: Chief Operating Officer | 2024-06-12 | S-Sale | 24.155 | 2024-06-12 |
| Mahal Jeetinder Singh | officer: Chief Operating Officer | 2024-06-12 | M-Exempt | 7.1 | 2024-06-12 |
| MARTELL RON | director, officer: President, CEO and Director | 2024-06-10 | A-Award | 0 | 2024-06-12 |
| MARTELL RON | director, officer: President, CEO and Director | 2024-06-10 | A-Award | 23.95 | 2024-06-12 |
| Tucker Edwin Jonathan | officer: Chief Medical Officer | 2024-06-07 | A-Award | 4.1735 | 2024-06-10 |
| French Anna Louise | director | 2024-06-06 | A-Award | 25.41 | 2024-06-10 |
| Nolet Chris | director | 2024-06-06 | A-Award | 25.41 | 2024-06-10 |
| Shizuru Judith Anne | director | 2024-06-06 | A-Award | 25.41 | 2024-06-10 |
| Kapoor Vishal | director | 2024-06-06 | A-Award | 25.41 | 2024-06-10 |
| WIGGANS THOMAS G | director | 2024-06-06 | A-Award | 25.41 | 2024-06-10 |
| Brun Scott C. | director | 2024-06-06 | A-Award | 25.41 | 2024-06-10 |
| EMSTER KURT VON | director | 2024-06-06 | A-Award | 25.41 | 2024-06-10 |
| Mahal Jeetinder Singh | officer: Chief Operating Officer | 2024-03-12 | M-Exempt | 7.1 | 2024-03-12 |
| Mahal Jeetinder Singh | officer: Chief Operating Officer | 2024-03-12 | S-Sale | 26.4358 | 2024-03-12 |
| Mahal Jeetinder Singh | officer: Chief Operating Officer | 2024-03-12 | M-Exempt | 7.1 | 2024-03-12 |
| MARTELL RON | director, officer: President, CEO and Director | 2024-02-15 | A-Award | 17.95 | 2024-02-20 |
| Mahal Jeetinder Singh | officer: Chief Operating Officer | 2024-02-15 | A-Award | 17.95 | 2024-02-20 |
| CROSS HERB | officer: Chief Financial Officer | 2024-02-15 | A-Award | 17.95 | 2024-02-20 |
| Tucker Edwin Jonathan | officer: Chief Medical Officer | 2024-02-15 | A-Award | 17.95 | 2024-02-20 |
| Carlyle Group Inc. | other: Former 10% Owner | 2024-02-08 | P-Purchase | 12.95 | 2024-02-12 |
| Velan Capital Investment Management LP | 10 percent owner | 2024-02-08 | P-Purchase | 12.95 | 2024-02-09 |
| WIGGANS THOMAS G | director | 2023-11-28 | P-Purchase | 0.6486 | 2023-11-30 |
| WIGGANS THOMAS G | director | 2023-11-21 | P-Purchase | 0.6383 | 2023-11-22 |
| WIGGANS THOMAS G | director | 2023-11-20 | P-Purchase | 0.6309 | 2023-11-20 |
| WIGGANS THOMAS G | director | 2023-11-17 | P-Purchase | 0.5966 | 2023-11-20 |
| WIGGANS THOMAS G | director | 2023-11-16 | P-Purchase | 0.5965 | 2023-11-20 |
| WIGGANS THOMAS G | director | 2023-11-01 | A-Award | 0.69 | 2023-11-02 |
| WIGGANS THOMAS G | director: | 2023-11-01 | 0 | 2023-11-02 | |
| Mahal Jeetinder Singh | officer: Chief Operating Officer | 2023-10-12 | F-InKind | 0.85 | 2023-10-13 |
| MARTELL RON | director, officer: President, CEO & Director | 2023-10-12 | F-InKind | 0.85 | 2023-10-13 |
| Lis William | director | 2023-10-13 | S-Sale | 0.8508 | 2023-10-13 |
| CROSS HERB | officer: Chief Financial Officer | 2023-09-22 | A-Award | 0.78 | 2023-09-26 |
| CROSS HERB | officer | 2023-09-22 | 0 | 2023-09-26 | |
| Brun Scott C. | director | 2023-06-20 | A-Award | 1.35 | 2023-06-20 |
| Brun Scott C. | director: | 2023-06-20 | 0 | 2023-06-20 | |
| Mahal Jeetinder Singh | officer: See Remarks | 2023-06-13 | M-Exempt | 0.71 | 2023-06-13 |
| Mahal Jeetinder Singh | officer: See Remarks | 2023-06-13 | S-Sale | 1.6572 | 2023-06-13 |
| Mahal Jeetinder Singh | officer: See Remarks | 2023-06-13 | M-Exempt | 0.71 | 2023-06-13 |
| Tucker Edwin Jonathan | officer: Chief Medical Officer | 2023-06-12 | A-Award | 1.62 | 2023-06-13 |
| Tucker Edwin Jonathan | officer | 2023-06-12 | 0 | 2023-06-13 | |
| Kapoor Vishal | director | 2023-06-07 | A-Award | 1.6 | 2023-06-08 |
| Klein Lawrence Otto | director | 2023-06-07 | A-Award | 1.6 | 2023-06-08 |
| EMSTER KURT VON | director | 2023-06-07 | A-Award | 1.6 | 2023-06-08 |
| Shizuru Judith Anne | director | 2023-06-07 | A-Award | 1.6 | 2023-06-08 |
| Nolet Chris | director | 2023-06-07 | A-Award | 1.6 | 2023-06-08 |
| Lis William | director | 2023-06-07 | A-Award | 1.6 | 2023-06-08 |
| French Anna Louise | director | 2023-06-07 | A-Award | 1.6 | 2023-06-08 |
| French Anna Louise | director | 2023-04-14 | S-Sale | 1.48 | 2023-04-14 |
| EMSTER KURT VON | director | 2023-04-13 | S-Sale | 1.4903 | 2023-04-14 |
| MARTELL RON | director, officer: President, CEO and Director | 2023-04-12 | F-InKind | 1.46 | 2023-04-14 |
| Mahal Jeetinder Singh | officer: See Remarks | 2023-04-12 | F-InKind | 1.46 | 2023-04-14 |
| Lis William | director | 2023-04-13 | S-Sale | 1.44 | 2023-04-14 |
| Qiming U.S. Healthcare Fund II, L.P. | 10 percent owner | 2023-01-27 | P-Purchase | 1.5 | 2023-04-11 |
| Mahal Jeetinder Singh | officer: See Remarks | 2023-03-17 | A-Award | 1.87 | 2023-03-20 |
| MARTELL RON | director, officer: President, CEO and Director | 2023-03-17 | A-Award | 1.87 | 2023-03-20 |
| Kapoor Vishal | director | 2023-02-16 | 0 | 2023-02-27 | |
| Kapoor Vishal | director | 2023-02-16 | A-Award | 1.83 | 2023-02-17 |
| Kapoor Vishal | director: | 2023-02-16 | 0 | 2023-02-17 | |
| Velan Capital Investment Management LP | 10 percent owner | 2023-01-25 | 0 | 2023-02-03 | |
| Velan Capital Investment Management LP | 10 percent owner | 2023-01-25 | 0 | 2023-02-03 | |
| Velan Capital Investment Management LP | 10 percent owner | 2023-01-25 | 11.5 | 2023-02-03 | |
| Velan Capital Investment Management LP | 10 percent owner | 2023-01-25 | 18 | 2023-02-03 | |
| Velan Capital Investment Management LP | 10 percent owner | 2023-01-25 | 15 | 2023-02-03 | |
| MARTELL RON | director, officer: President, CEO & Director | 2023-02-02 | A-Award | 1.78 | 2023-02-03 |